LVTXLAVA Therapeutics NV

$1.74
$0.00
(0.00%)
Pre-Market
Updated: 12:00 AM EST·Prev Close $1.74
Reported EarningsAug 13
Mkt Cap$45.77M
Vol285,521.00
News
all
press releases
News Placeholder
LAVA Therapeutics Stock Drops After Amended Deal With XOMA Royalty
As per the amended deal, LAVA shareholders will receive an initial cash payment of $1.04 per share, down from the range of $1.16 to $1.24 initially agreed upon.
Stocktwits
News Placeholder
LAVA Therapeutics Stock Slips 9% Pre-Market – Here’s Why The Company Canceled Its Shareholder Meeting
The firm stated it canceled the meeting to consider and approve certain matters related to its proposed transaction with XOMA Royalty Corporation.
Stocktwits
<
...
1
>